Outseer™ Releases Latest Fraud & Payments Report Showing Authorized Push Payment (APP) Fraud is Rife
75% of Fraudulent Online Banking Activity Originates from a Trusted Account on a Trusted Device…
Month: September 2022
Wolters Kluwer Names Chris Sullivan Vice President Commercial Segment for Clinical Effectiveness
WALTHAM, Mass.–(BUSINESS WIRE)–Wolters Kluwer, Health today announced that Christopher Sullivan has been appointed as Vice…
Thinner, Lighter, and Faster: Amazon Introduces All-New Fire HD 8 Tablets Built for Entertainment
All-new Fire HD 8 features an 8-inch HD display, 30% faster performance, and up to…
Enabled Intelligence, Inc., Expands Headquarters in Fairfax County, Creates 117 New Jobs
FAIRFAX COUNTY, Va.–(BUSINESS WIRE)–Earlier today, Governor Glenn Youngkin announced that Enabled Intelligence, Inc., a provider…
BostonGene Showcases Lifesaving Cancer Diagnostic and Treatment Recommendation Test at The 81st Annual Meeting of the Japanese Cancer Association
Presentations Demonstrate the Power of Integrated Analysis to Discover Distinct Characteristics of the Tumor Microenvironment…
Paul Galant Joins CompoSecure’s Board of Directors
Industry Veteran Brings Deep Expertise in Payments, eCommerce, and Security, from Verifone and Other Notable…
First-in-the-Nation Legislation Requiring Health Exchange to Operate as State Health Data Utility to Take Effect Oct. 1 in Maryland
CRISP, Maryland’s state-designated health information exchange, to assist in the collection, analysis and evaluation of…
Fighting Fire with 5G – T-Mobile 5G Powers Pano AI Wildfire Detection System
What’s the news: T-Mobile, Pano AI and Portland General Electric are deploying 5G-connected cameras to…
Perforce Joins the Global Semiconductor Alliance and Debuts IP Maturity Model
San Jose, Calif. Wednesday, September 21, 2022 – Perforce Software, a provider of solutions to…
Praxis Precision Medicines to Present at Guggenheim Nantucket Therapeutics Conference
BOSTON, Sept. 21, 2022 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage…
eFFECTOR Therapeutics to Present at Cantor Oncology, Hematology, HemeOnc Conference
– Presentation Scheduled for Wednesday, September 28 from 10:40-11:20 AM ET – SAN DIEGO and…
Akadeum Life Sciences Announces New Early Access Launch of First-of-its-Kind Microbubble-Powered, Large-Scale Cell Isolation Kit for Leukopaks
Akadeum’s microbubble technology allows scientists to effortlessly process up to twice as many leukopaks in…
AIM ImmunoTech to Present at the Virtual Investor Long COVID Event
Live video webcast with moderated roundtable between members of the AIM ImmunoTech Management Team and…
Helsinn presents novel data on Chlormethine gel at EORTC cutaneous lymphomas tumors group annual meeting
Helsinn presents novel data on Chlormethine gel at EORTC cutaneous lymphomas tumors group annual meeting…
AVEO Oncology Announces Participation at the Cantor Fitzgerald Oncology & HemOnc Conference
BOSTON, Sept. 21, 2022 (GLOBE NEWSWIRE) — AVEO Oncology (Nasdaq: AVEO), a commercial stage, oncology-focused…
Veru to Participate in the Cantor Oncology, Hematology & HemeOnc Conference on September 28th, 2022
MIAMI, Sept. 21, 2022 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused…
BrightInsight and bioMérieux Announce Partnership to Launch Clinical Digital Solutions for Diagnostics
bioMérieux’s Solutions Aim to Improve Clinical Workflow and Deliver Actionable Data to Cross-functional Care Teams…
Entera Bio Hosting Key Opinion Leader Webinar on the Treatment Landscape for Osteoporosis and EB613’s Potential Impact on Wednesday, September 28th @ 10am ET
JERUSALEM, Sept. 21, 2022 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the…
Zealand Pharma Announces Oral Presentation of Phase 2 Data for BI 456906 at the 58th Annual Meeting of the European Association for the Study of Diabetes (EASD)
Press release – No. 6 / 2022 Zealand Pharma Announces Oral Presentation of Phase 2…
Genelux Corporation Initiates a Pivotal Phase 3 Trial, Evaluating Olvi-Vec for the treatment of Platinum-Resistant/Refractory Ovarian Cancer
The Company’s first Phase 3 trial, OnPrime (GOG-3076), will evaluate Olvi-Vec, a modified vaccinia virus,…